Preventive factors, diagnosis, and management of injection-related endophthalmitis: a literature review Rupali SinghSamaneh DavoudiSteven Ness Review Article 12 March 2022 Pages: 2399 - 2416
The Cologne-Mecklenburg-Vorpommern DMEK Donor Study (COMEDOS) — design and review of the influence of donor characteristics on Descemet membrane endothelial keratoplasty (DMEK) outcome Silvia SchrittenlocherMario MatthaeiClaus Cursiefen Review Article Open access 16 March 2022 Pages: 2417 - 2426
Post-enucleation socket syndrome—a novel pathophysiological definition Alexander C. RokohlAdam KopeckyLudwig M. Heindl Mini Review Open access 02 April 2022 Pages: 2427 - 2431
Combined epiretinal and internal limiting membrane retracting door flaps for large macular holes associated with epiretinal membranes Elizabeth D. MarlowSaaquib R. BakhshTamer H. Mahmoud Retinal Disorders 01 March 2022 Pages: 2433 - 2436
Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR K. Bailey FreundGiovanni StaurenghiShamika Gune Retinal Disorders 03 March 2022 Pages: 2437 - 2447
Systemic and vitreous biomarkers — new insights in diabetic retinopathy Bernardete PessoaJoão HeitorMelo Beirão Retinal Disorders 24 March 2022 Pages: 2449 - 2460
Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration Abdallah AbbasCiara O’ByrnePearse A. Keane Retinal Disorders Open access 05 February 2022 Pages: 2461 - 2473
Regression patterns of central serous chorioretinopathy using en face optical coherence tomography Supriya AroraBrian RosarioOn behalf of Central Serous Chorioretinopathy Study Group Retinal Disorders 31 March 2022 Pages: 2475 - 2481
Optical coherence tomography angiography quantification of choriocapillaris blood-flow after half-fluence photodynamic therapy for chronic central serous chorioretinopathy Hoang Mai LeSarah MrejenSalomon Y. Cohen Retinal Disorders 29 March 2022 Pages: 2483 - 2490
Cardiac autonomic neuropathy predicts diabetic retinopathy progression in Asian population with type 2 diabetes mellitus Chu-Yu YenChun-Sen ChenI-Mo Fang Retinal Disorders 29 March 2022 Pages: 2491 - 2499
Screening of telangiectatic capillaries in chronic macular edema based on multimodal imaging: a study of 101 eyes. LyoMAC1 study Mayeul ChaperonLaurent KodjikianCorinne Dot Retinal Disorders 16 February 2022 Pages: 2501 - 2508
Outcomes after switching eyes that were stable on aflibercept to ranibizumab versus continuing aflibercept in neovascular age-related macular degeneration Mirataollah SalabatiAnthony Obeidthe Wills Switch Study Group Retinal Disorders 01 March 2022 Pages: 2509 - 2516
Full-field sensitivity threshold and the relation to the oxygen metabolic retinal function in retinitis pigmentosa Olga ZabekGiacomo CalzettiMaria della Volpe Waizel Retinal Disorders 31 March 2022 Pages: 2517 - 2527
Sub-Tenon’s capsule triamcinolone acetonide injection to prevent brolucizumab-associated intraocular inflammation Taiichi Hikichi Retinal Disorders 02 March 2022 Pages: 2529 - 2535
Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)—results from the ILUVIT study Svenja K. DeuchlerRalf SchubertFrank Koch Retinal Disorders Open access 03 March 2022 Pages: 2537 - 2547
Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration: 24-month outcomes Hyeong Min KimNa-Kyung RyooKyu Hyung Park Retinal Disorders 21 March 2022 Pages: 2549 - 2559
Brolucizumab for pre-treated patients with choroidal neovascularization and signs of tachyphylaxis to aflibercept and bevacizumab Agnes BoltzKatharina RadunskyVeronika Pia Vécsei-Marlovits Retinal Disorders 29 March 2022 Pages: 2561 - 2566
Carvacrol protects the ARPE19 retinal pigment epithelial cells against high glucose-induced oxidative stress, apoptosis, and inflammation by suppressing the TRPM2 channel signaling pathways Hatice DaldalMustafa Nazıroğlu Basic Science 15 June 2022 Pages: 2567 - 2583
Characterizing the microbiota of instrumentation in ophthalmology clinics during and beyond the COVID-19 pandemic Heba MahjoubSean X. ZhangMark P. Breazzano Basic Science 31 March 2022 Pages: 2585 - 2590
Adjusted femtosecond laser capsulotomy distance in white cataracts to decrease incomplete capsulotomy: a randomized comparative cohort study Zeli ChenYan WuZhen Liu Cataract 26 March 2022 Pages: 2591 - 2595
Macular vascular density and visual function after phacoemulsification in cataract patients with non-pathological high myopia: a prospective observational cohort study Yu YangZhibing ZengWei Fan Cataract 08 March 2022 Pages: 2597 - 2604
Automated vs. human evaluation of corneal staining R. KourukmasM. RothG. Geerling Cornea Open access 31 March 2022 Pages: 2605 - 2612
Outcomes and complications of cataract surgery in patients with chronic ocular graft-versus-host-disease—a multicenter, retrospective analysis Uta GehlsenChristiane FaustPhilipp Steven Cornea Open access 07 March 2022 Pages: 2613 - 2622
Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis Sébastien RoumeauFrédéric DutheilValentin Navel Cornea 07 March 2022 Pages: 2623 - 2637
Predictability of success and open conjunctival revision rates in the subsequent eye after XEN45 Gel Stent implantation according to lens status D. KiesslingC. RenningsR.A. Widder Glaucoma Open access 03 February 2022 Pages: 2639 - 2647
Does mitomycin-C concentration have any influence on XEN45 gel stent outcomes in a real-world setting? Natalia Monja-AlarcónSusana Perucho-MartínezNicolás Toledano-Fernández Glaucoma 01 March 2022 Pages: 2649 - 2661
Ultrastructural analysis of explanted CyPass microstents and correlation with clinical findings Lisa HübnerU. Schlötzer-SchrehardtR. Lämmer Glaucoma Open access 09 March 2022 Pages: 2663 - 2673
Increased vitreous levels of B cell activation factor (BAFF) and soluble interleukin-6 receptor in patients with macular edema due to uveitis related to Behçet’s disease and sarcoidosis Atsunobu TakedaEiichi HasegawaKoh-Hei Sonoda Inflammatory Disorders 01 March 2022 Pages: 2675 - 2686
Analysis of microvascular and neurodegenerative complications of mild COVID-19 Zsofia KolkediAdrienne CsutakEszter Szalai Inflammatory Disorders Open access 19 March 2022 Pages: 2687 - 2693
A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration—the FALCON study F. G. HolzSteffen Schmitz-ValckenbergK. Jaeger Medical Ophthalmology Open access 21 February 2022 Pages: 2695 - 2702
Mid-term safety and effectiveness of intravitreal dexamethasone implant to treat persistent cystoid macular edema in vitrectomized eyes for bacterial endophthalmitis Giancarlo SborgiaAlfredo NiroGiovanni Alessio Medical Ophthalmology 07 March 2022 Pages: 2703 - 2710
Evaluation of peripapillary vascular flow in patients with Thyroid-Associated Ophthalmopathy (TAO) by OCT Angiography Chiara Del NoceMatilde RodaAldo Vagge Neurophthalmology Open access 12 February 2022 Pages: 2711 - 2716
Genetic polymorphisms of apolipoprotein E in nonarteritic anterior ischemic optic neuropathy Yuyu ChouZixi SunYong Zhong Neurophthalmology 08 March 2022 Pages: 2717 - 2726
Clinical profile of 80-year-old and older thyroid eye disease patients Niv LevyHana LeibaRuth Huna-Baron Neurophthalmology 26 March 2022 Pages: 2727 - 2736
The histopathological findings in excised upper eyelids of patients with dermatochalasis following collagen cross-linking treatment Ali Mert KocerEmine Malkoc SenSema Hucumenoglu Oculoplastics and Orbit 16 March 2022 Pages: 2737 - 2743
The use of HCT and/or ACE inhibitors significantly increases the risk of non-melanotic skin cancer in the periocular region Juliane MehlanJulian UeberschaarF. Schuettauf Oculoplastics and Orbit Open access 17 February 2022 Pages: 2745 - 2751
Partial monovision achieved by unilateral implantation of a multifocal add-on lens with bilateral pseudophakia: evaluation and results Vitus André KnechtHoraţiu Alexandru ColosiAndrea Hassenstein Refractive Surgery Open access 17 February 2022 Pages: 2753 - 2762
Long-term follow-up for monovision surgery by Implantable Collamer Lens V4c implantation for myopia correction in early presbyopia Yuhao YeJing ZhaoXingtao Zhou Refractive Surgery Open access 07 February 2022 Pages: 2763 - 2771
The thin line between seeing risks and venturing scientific progress Moritz Lindner Letter to the Editor Open access 03 February 2022 Pages: 2773 - 2774
Visualising the risks of clinical trials for fair treatment and appropriate informed consent of participants Alexander R. HarrisFrederic Gilbert Letter to the Editor (by invitation) 12 January 2022 Pages: 2775 - 2776
Correction to: Predictability of success and open conjunctival revision rates in the subsequent eye after XEN45 Gel Stent implantation according to lens status D. KiesslingC. RenningsR. A. Widder Correction Open access 03 March 2022 Pages: 2777 - 2777